Indication intelligence, analysis and sector perception

Lower open expected; RegMed Investors’ (RMi) pre-open, JPMorgan's annual health-care conference is about to start in San Francisco

January 5, 2017 7:42am

What is an iteration of the old saying, “BUY, pre the confab and SELL post the presentations or was it the congestion”

Last night’s upside closing number embraces bottom-fishing; we will be back in the battle of the overbought versus the oversold

I answer one question; in which company should investors put, keep and commit their money!

Who is in today’s headlights – seven (7) equities, are they a BUY or a SELL?

Miss me, it’s time to become a 2017 subscriber – free reads are over!

I write in every line that investors need to avoid risks as if I were the first to be hurt if I am wrong!

Members only. Please login.

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.